DRI
60
4
HPQ
57
-5
ECL
64
-16
ADI
61
-2
DAL
46
-12
GLW
65
-6
CPB
37
2
SPG
56
-5
GD
57
-2
VNO
51
2
SLB
32
-3
RSG
70
2
WRK
50
-3
FTI
61
-3
BSX
67
-2
MS
57
-2
NKE
40
-3
DO
60
-2
ITW
70
11
NI
60
-2
DRI
60
4
HPQ
57
-5
ECL
64
-16
ADI
61
-2
DAL
46
-12
GLW
65
-6
CPB
37
2
SPG
56
-5
GD
57
-2
VNO
51
2
SLB
32
-3
RSG
70
2
WRK
50
-3
FTI
61
-3
BSX
67
-2
MS
57
-2
NKE
40
-3
DO
60
-2
ITW
70
11
NI
60
-2
Financhill
Back

Royal Gold Vs. Cytokinetics Industry Stock Comparison

Sell
46

RGLD
Royal Gold

Last Price:
121.68
Seasonality Move:
7.97%
Buy
55

CYTK
Cytokinetics

Last Price:
53.96
Seasonality Move:
7.55%
Sell
46
Royal Gold (RGLD) is a Sell

Is Royal Gold a Buy, Sell or Hold?

  • The current Royal Gold [RGLD] share price is $121.63. The Score for RGLD is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • RGLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $53.93. The Score for CYTK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RGLD Stock Price Chart

What is Royal Gold's stock price today?

  • The Royal Gold share price today is $121.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGLD is experiencing buying pressure, which is a positive indicator for future bullish movement.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $53.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

RGLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 40.27 Sell
Chaikin Money Flow: 210674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.17 - 131.49) Sell
Bollinger Bands (100): (110.41 - 126.59) Buy

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.04 Sell
Relative Strength Index (14 RSI): 46.58 Sell
Chaikin Money Flow: 781761 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.51 - 58.99) Sell
Bollinger Bands (100): (57.71 - 76.51) Sell

RGLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 124.2 Sell
20-day SMA: 127.67 Sell
50-day SMA: 125.16 Sell
200-day SMA: 115.94 Buy
8-day EMA: 123.57 Sell
20-day EMA: 125.53 Sell
50-day EMA: 124.2 Sell
200-day EMA: 118.77 Buy

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.47 Buy
20-day SMA: 52.83 Buy
50-day SMA: 60.85 Sell
200-day SMA: 55.3 Sell
8-day EMA: 53.07 Buy
20-day EMA: 54.08 Sell
50-day EMA: 58.8 Sell
200-day EMA: 57.11 Sell

Royal Gold Earnings Growth & RGLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.10 per share, an increase this year of $1.05 per share, and an increase next year of $1.21 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.01 per share, an increase this year of $0.60 per share, and an increase next year of $0.05 per share.

Royal Gold Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):